Skip to main content
OpenTrials
Completed

NCT Number: NCT02448316

Plantar Fasciitis, Operation or Conservative Treatment

The purpose of this study is to compare in a randomized controlled trial the effect of endoscopic operation with the standard conservative treatmentprotocol with training supplemented with 1-3 injections of glucocorticoids in patients with chronic plantar fasciopathia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Institute of Sports Medicine Copenhagen, Bispebjerg Hospital

Copenhagen, 2400, Denmark

About this study

Plantars fasciitis (PF) is a frequently diagnosed condition, defined as pain at the medial tubercle of the calcaneus, and 10% of the population will at some points in their life experience this condition. Accumulated loading of the plantar fascia seems to relate to development of PF, as it is commonly seen in runners and those who are overweight, and number of daily steps or simply time of standing has been shown to be a predisposing factor for PF development ( Orthosis and glucocorticoid injections are 2 widely used treatments and in most clinics the standard treatment, despite the fact that a recent Cochrane review found limited evidence for treatment of plantar heelpain.

Once the condition gets chronic the response to several kinds of treatment is less predictable. However it has been demonstrated that endoscopic surgery for plantar fasciitis using a deep-fascial approach was successful in individuals with an active sports anamnesis, and all patients returned with this treatment to full athletic activities within 8-15 weeks. This high succesrate is not seen in conservative treatment with decrease in activity, training and injections of glucocorticosteroid, eventhough they had shorter disease duration. Therefore the investigators think it would be interesting to offer this minimal invasive operation to patients much earlier in the disease, especially as there is no reported severe sideeffects .

However, surgery is very seldom compared with results of other treatment modalities, and no randomized studies exist on the effect of operation vs the normal conservative standard-treatment.

The purpose of this study is to compare in a randomized controlled trial the effect of endoscopic operation with the standard conservative treatmentprotocol with training supplemented with 1-3 injections of glucocorticoids in patients with chronic plantar fasciopathia.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • pain at the medial attachment of fascia plantaris
  • first step pain in the morning
  • symptoms for at least 3 months
  • ultrasound scanning at the first visit shows thickness of the proximal fascia above 4 mm
  • patient can read and understand danish

Exclusion criteria

  • known arthritis inflammatory bowl disease, psoriasis or clinical signs of any of these.
  • leg ulcerations
  • long lasting oedema of the leg and foot
  • palpatory decreased puls in the foot
  • diabetes
  • reduced sensibility in the foot
  • infections in the foot
  • daily use of pain killers
  • pregnancy or planning to become pregnant
  • earlier operations on the foot, that is judged to complicate training.
  • patients assessed not to be able to participate in the training for other reasons
  • Glucocorticosteroid injection to the diseased plantar fascia within the last 6 months

Treatment and study plan

endoscopic surgery

Procedure

Through 2 portals profound for the fascia plantaris (deep-fascial) lateral and medial a heel-spur will be resected and the medial half of the fascia is released from its attachment to the calcaneus.

A mikroskopic X-ray sensitive pearle (Tantalum-pearle) will be inserted in the fascia in the proximal end of the distal part of the remaining fascia for measuring distance (resorbtion).

Three weeks after operation, the patients are instructed to start a specific training program. Training is supervised every third week by a physiotherapist (week 3,6,9,12 after operation), and daily training is carried out at home. Sutures are removed after 10 days,

Other names: Fascial release, Heel spur resection, Training

methylprednisolon

Drug

1ml methylprednisolon is mixed with 1ml of Lidocain and injected underneath the plantar fascia as close to the medial attachment on calcaneus as possible

Other names: Depo-medrol, Glucocorticosteroid injection

lidokaine

Drug

1ml methylprednisolon is mixed with 1ml of Lidocain and injected underneath the plantar fascia as close to the medial attachment on calcaneus as possible

Other names: Xylocain

Training

Behavioral

the patient is instructed in reduction in impact. strength training 3 times weekly and stretching exercises daily are recommended.

Other names: strength training, stretching

Primary outcomes

  1. Foot Function Index

    Time frame: 6 months

    Foot Function Index (FFI) is a validated score usefull for plantar fasciitis. It consists of 23 questions concerning pain, function and impact on daily life. Each question is answered on a box scale 0-10, giving a score range: 0-230

  2. Foot Function Index

    Time frame: 12 months

    Foot Function Index (FFI) is a validated score usefull for plantar fasciitis. It consists of 23 questions concerning pain, function and impact on daily life. Each question is answered on a box scale 0-10, giving a score range: 0-230

Secondary outcomes

  1. 100 mm VAS score for morning pain

    Time frame: 3 months

  2. 100 mm VAS score for morning pain

    Time frame: 6 months

  3. 100 mm VAS score for morning pain

    Time frame: 12 months

  4. 100 mm VAS score for morning pain

    Time frame: 24 months

  5. 100 mm VAS score for pain at function

    Time frame: 3 months

  6. 100 mm VAS score for pain at function

    Time frame: 6 months

  7. 100 mm VAS score for pain at function

    Time frame: 12 months

  8. 100 mm VAS score for pain at function

    Time frame: 24 months

  9. single leg jumping length

    Time frame: 12 months

    Standing on the diseased leg, the patient jumps as far as possible landing on the same leg. the best of 3 trials.

  10. positionel MR scanning (pMRI)

    Time frame: 12 months

    only for the operated patients the change in bone position in standing is measured using a pMRI, where bone position is measured in supine and standing before and 12 months after the operation. This will also include patients referred directly to operation and therefore not included in the RCT

  11. Tantalum pearle-calcaneus distance

    Time frame: 12 months

    only for operated patients the distance from calcaneus to a Tantalum pearle inserted in the plantar fascia during operation is measured by lying and standing X-ray. This will also include patients referred directly to operation and therefore not included in the RCT

  12. Foot Function Index

    Time frame: 24 months

    Foot Function Index (FFI) is a validated score usefull for plantar fasciitis. It consists of 23 questions concerning pain, function and impact on daily life. Each question is answered on a box scale 0-10, giving a score range: 0-230

Sponsors and collaborators

Lead sponsor

Bispebjerg Hospital

Other

Collaborators

  • The Danish Rheumatism Association

Registry information

Official study title

Randomized Clinical Trial Comparing Conventional Conservative Treatment for Plantar Fasciopathia With Endoscopic Surgery With Fascial Release.

Important dates

Study start
2015
Primary completion
2016
Study completion
2017
First posted
May 19, 2015
Registry last updated
Jul 11, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.